This will be a 2-3 hour webinar for representatives from medical device companies who are tasked with compliance to the upcoming Restriction of Hazardous Substances (RoHS) 2 directive deadline in July 2014. The directive reflects small, but important changes in definitions to EEE and the scope of materials which are now not allowed to be in new products coming to the market in Europe.

NextLevel Pharma's focused and interactive webinar will look to quickly answer the questions you may have regarding your products nature and it's requirement for compliance, any possible exemptions that are available which may apply and learn from well-prepared device manufacturers how to quickly become compliant from both a product specific and a manufacturing / operational design perspective.

Why This Event?

  • Learn from Hogan Lovell's expert legal advice on what the directive means to you, if your products are in scope and what the consequences may be if you are not compliant.
  • Hear from Oko Institut, who assess and advise on RoHS 2 medical device exemptions for the European Commission, as to how and where exemptions exist and what is the application & exemption submission process.
  • Experience TÜV SÜD's depth of expertise and solution-minded approach to achieving compliance with RoHS2. Ask your questions to learn if this is applicable to your products or to simply confirm with confidence that your products are prepared and that nothing else needs to be done.

Webinar: 11th February 2014, 4pm (CET), 3 pm (GMT), 10am (EST)

To request the full agenda please follow the link here.